We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of JAMA |

Highlights FREE

JAMA. 2014;312(12):1173-1175. doi:10.1001/jama.2013.279739.
Text Size: A A A
Published online


Guidelines for prenatal genetic testing recommend that patients receive detailed information to allow informed, preference-based screening and diagnostic testing decisions. In a randomized trial that enrolled 710 demographically diverse pregnant women, Kuppermann and colleagues found that compared with usual care, access to a computerized, interactive prenatal testing decision support guide—providing information and values clarification exercises—and elimination of any out-of-pocket costs associated with prenatal diagnostic testing resulted in less prenatal test use and more informed and preference-based prenatal testing decisions. In an Editorial, Dolan discusses the promise and challenges of personalized prenatal genetic testing.

To examine long-term trends in the prevalence and incidence of diagnosed diabetes in US adults, Geiss and colleagues analyzed data from nearly 665 000 adults who participated in the 1980-2012 National Health Interview Surveys. The authors report their analyses suggest an overall plateauing of prevalence and incidence of diagnosed diabetes since 2008. However, among certain subgroups, including non-Hispanic blacks, Hispanics, and persons with less than a high school education, continued increases in prevalence and incidence were observed.

Positron emission tomography (PET) with fludeoxyglucose F 18 (FDG) is recommended for the noninvasive diagnosis of pulmonary nodules suspicious for lung cancer. However, data suggest FDG-PET may not accurately identify malignant lesions in populations with endemic infectious lung disease. In a systematic review and meta-analysis of data from 70 studies of lung cancer diagnosis using FDG-PET, Deppen and colleagues found FDG-PET accuracy was quite heterogeneous and diagnostic specificity was lower in endemic infectious lung disease populations.


Checchi and colleagues assessed whether electronic medication packaging devices improve medication adherence in a systematic review and analysis of data from 37 studies examining the effectiveness of these devices. The authors found that there are many varieties of electronic medication packaging devices and note that data supporting their use are limited. The authors report that devices integrated into the care delivery system and those with audible reminder alarms that are designed to record dosing events were most frequently associated with improvements in medication adherence.

Lung cancer is the leading cause of cancer mortality in the United States. This JAMA Clinical Guidelines Synopsis article summarizes the 2014 US Preventive Services Task Force recommendations relating to lung cancer screening of asymptomatic adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit smoking within the past 15 years. In an Editorial, Sox discusses concerns about implementing lung cancer screening in Medicare-aged patients. An Editorial by Cifu and colleagues introduces this new JAMA series.

Editorials 1 and 2 and Related Article

A man with a history of travel to the Venezuelan rainforest presented with an erythematous plaque on the neck and erythema and swelling of the left nasal ala with disruption of the nasal architecture and crusting of the naris. Treatment over the past 3 months with a variety of oral, intramuscular, and topical antibiotics had not been beneficial. Biopsy of the nasal tissue revealed reactive hyperplasia and inflammation; no organisms were found using special stains. What would you do next?



Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.